NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which class of medications is known for directly stimulating insulin secretion from pancreatic beta-cells?

SGLT2 inhibitors
Insulin secretagogues
GLP-1 agonists
DPP-4 inhibitors

The correct answer is: Insulin secretagogues

Insulin secretagogues are a class of medications known for directly stimulating insulin secretion from pancreatic beta-cells. These medications work by binding to specific receptors on the beta-cells, leading to an increase in insulin release. Option A, SGLT2 inhibitors, work by inhibiting the sodium-glucose cotransporter 2 in the renal tubules, reducing reabsorption of glucose and increasing urinary glucose excretion. Option C, GLP-1 agonists, mimic the effects of the incretin hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner and also inhibits glucagon secretion and gastric emptying. Option D, DPP-4 inhibitors, work by inhibiting the enzyme dipeptidyl peptidase-4, which degrades incretin hormones like GLP-1. By inhibiting DPP-4, these medications increase the levels of endogenous GLP-1, leading to improved glucose-dependent insulin secretion.